Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

INSM Insmed, Inc.
$158.49 -0.20% -0.32
Notify me if price changes either direction
Interactive Brokers Logotype

Buy INSM stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 33.8B
Enterprise value 34.9B
Trailing PE -28.479354557058
Forward PE 436.7667
PEG Ratio -0.75351625598882
Enterprise to EBITDA -35.561
Enterprise to revenue 57.495
Price to book MRQ 47.81386
Price to sales TTM 57.99736

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 606.4M
EBITDA -980464000
Diluted EPS TTM -6.18
Total Cash (MRQ) 1.4B
Current ratio (MRQ) 3.827
Operating Cash Flow (TTM) -935014016

INSM trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent INSM News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.